Home » Stocks » ABBV

AbbVie Inc. (ABBV)

Stock Price: $118.87 USD 0.32 (0.27%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $118.50 -0.37 (-0.31%) Jul 29, 5:21 PM
Market Cap 209.96B
Revenue (ttm) 50.20B
Net Income (ttm) 5.16B
Shares Out 1.77B
EPS (ttm) 2.91
PE Ratio 40.81
Forward PE 9.50
Dividend $4.96
Dividend Yield 4.17%
Trading Day July 29
Last Price $118.87
Previous Close $118.55
Change ($) 0.32
Change (%) 0.27%
Day's Open 119.03
Day's Range 118.15 - 119.13
Day's Volume 4,630,164
52-Week Range 76.40 - 119.13

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

AbbVie (ABBV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

5 hours ago - Zacks Investment Research

Venclexta's potential indication for the treatment of myelodysplastic syndrome could mean billions for AbbVie this decade.

7 hours ago - The Motley Fool

These two companies will be excellent buys in the event of another coronavirus-fueled market crash.

Other stocks mentioned: NFLX
9 hours ago - The Motley Fool

NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of BOTOX® to ...

9 hours ago - PRNewsWire

Cryptomania isn't all it's cracked up to be.

Other stocks mentioned: MELI
1 day ago - The Motley Fool

Let's explore two blue chip stocks that investors might want to consider buying as they report Q2 earnings.

Other stocks mentioned: AAPL, AMZN, CAT, CMI, F, MSFT, TSLA
2 days ago - Zacks Investment Research

AbbVie's (ABBV) second-quarter results are expected to reflect the impact of strong demand for new drugs. Investors are likely to focus on any update related to guidance.

2 days ago - Zacks Investment Research

AbbVie Inc (NYSE: ABBV) and Calico Life Sciences have collaborated to discover and develop new therapies for patients with age-related diseases, including neurodegeneration and cancer.  It is the second...

2 days ago - Benzinga

AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and… The post AbbVie Inc. (ABBV) and Calico Announce Second Extension of Collaboration appeared first on Marijuana Stocks | ...

2 days ago - MarijuanaStocks

NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif.

2 days ago - PRNewsWire

Time and time again, the Wall Street pundits say interest rates are going higher, and time and time again they plunge lower.

Other stocks mentioned: CVX, LYB, PM, VZ
2 days ago - 24/7 Wall Street

AbbVie (ABBV) closed at $117.79 in the latest trading session, marking a -0.34% move from the prior day.

2 days ago - Zacks Investment Research

The dividend isn't always the top reason to like Dividend Aristocrats.

Other stocks mentioned: LOW, PEP
3 days ago - The Motley Fool

NORTH CHICAGO, Ill., July 25, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced new data, including the full results from the Phase 3 GEMINI 1 clinical study, evaluating the...

4 days ago - PRNewsWire

You'll be able to lock in fantastic dividend yields if you do.

Other stocks mentioned: DEA, EPD
4 days ago - The Motley Fool

These stocks are cheap, but their underlying businesses are solid.

Other stocks mentioned: CVS, PFE
5 days ago - The Motley Fool

AbbVie (ABBV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 days ago - Zacks Investment Research

AbbVie (ABBV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

6 days ago - Zacks Investment Research

NORTH CHICAGO, Ill., July 23, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved DALVANCE® (dalbavancin) for the treatment of acute bacter...

6 days ago - PRNewsWire

If you're looking for dividend stocks to own from the S&P 500, these 10 Dividend Aristocrats are doing a lot better than most. The post The 10 Best Dividend Income Growers in the S&P 500 appeared first ...

Other stocks mentioned: ADP, AOS, HRL, MDT, NEE, SHW, SPGI ...
1 week ago - InvestorPlace

The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come.

Other stocks mentioned: AMGN, BMY, FHLC, GILD, IYH, JNJ, MRK ...
1 week ago - Zacks Investment Research

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?

1 week ago - Zacks Investment Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 week ago - Zacks Investment Research

The FDA grants a Breakthrough Therapy designation to AbbVie's (ABBV) Venclexta in combination with azacitidine for treating adult patients with higher risk myelodysplastic syndrome.

1 week ago - Zacks Investment Research

We have covered the Dividend Aristocrats stocks for years here at 24/7 Wall St. So it was kind of a seismic shock back in the spring when AT&T, a long-time charter member of the list, announced it would...

Other stocks mentioned: IBM, O, WBA, XOM
1 week ago - 24/7 Wall Street

NORTH CHICAGO, Ill., July 21, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy Designation (BTD) to venetoclax (VE...

1 week ago - PRNewsWire

NORTH CHICAGO, Ill., July 20, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that it will present new data from its leading portfolio of eye care medicines at the 2021 AS...

1 week ago - PRNewsWire

In the latest trading session, AbbVie (ABBV) closed at $115.42, marking a -1.77% move from the previous day.

1 week ago - Zacks Investment Research

The FDA will not meet its action dates for AbbVie's (ABBV) sNDA for JAK inhibitor drug, Rinvoq (upadacitinib), for moderate to severe atopic dermatitis.

1 week ago - Zacks Investment Research

These dividend stocks are standouts from the Dividend Aristocrats list. They have yields higher than 4% and can consistently raise dividends.

Other stocks mentioned: CVX, O
1 week ago - InvestorPlace

There are important things to watch with each of these stocks.

Other stocks mentioned: BIIB, MRNA, PFE
1 week ago - The Motley Fool

Migraine sufferers certainly hope so.

Other stocks mentioned: BHVN
1 week ago - The Motley Fool

Among members of Big Pharma, Novartis AG ( NVS , Financial) brought the most novel medicines to market in the past five years, according to a report from Evaluate Vantage.

Other stocks mentioned: LLY, NVS
1 week ago - GuruFocus

AbbVie Inc (NYSE: ABBV) and Eli Lilly And Co (NYSE: LLY) will have to keep waiting for a chance for their JAK inhibitors in atopic dermatitis to see the market. The companies separately said on Friday t...

Other stocks mentioned: LLY
1 week ago - Benzinga

These dividend stocks are fundamentally strong companies with solid earnings bases. Thus, their dividend payouts are safe and sustainable.

Other stocks mentioned: ETRN, JXI, MO, NLY, SPYD, T
1 week ago - InvestorPlace

We believe that the stock price of AbbVie has more room for growth from its current levels of $117. ABBV stock is up 95% from the levels of around $60 it was at on March 23, 2020, when the broader marke...

1 week ago - Forbes

NORTH CHICAGO, Ill., July 16, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) did not meet the Prescription Drug User Fee Act (PDUFA) action date for...

1 week ago - PRNewsWire

Big Pharmaceutical Companies That Are Top Medicinal Cannabis Stocks The post Best Medical Marijuana Stock To Buy In 2021? 2 With Long Term Potential Right Now appeared first on Marijuana Stocks | Cannab...

Other stocks mentioned: JAZZ
2 weeks ago - MarijuanaStocks

AbbVie (ABBV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 weeks ago - Zacks Investment Research

AbbVie (ABBV) closed the most recent trading day at $117.63, moving +0.9% from the previous trading session.

2 weeks ago - Zacks Investment Research

There's no shortage of stocks with dividends these days, but not all of them are worth chasing. Here's a list of top-rated, high-yielding names to consider.

Other stocks mentioned: CVX, EIX, GLPI, HBAN, LYB, MPW, O ...
2 weeks ago - Kiplinger

While growth names still dominate the mainstream narrative, it's wise to consider some exposure to safety in dividend stocks. The post 7 Super-Safe Dividend Stock Performers to Buy appeared first on Inv...

Other stocks mentioned: AAPL, ABT, COST, KO, PG, PRU
2 weeks ago - InvestorPlace

AstraZeneca (AZN), AbbVie (ABBV) and Bayer (BAYRY) are three large drug sector companies worth buying now.

Other stocks mentioned: AZN, BAYRY
2 weeks ago - Zacks Investment Research

AbbVie Inc.'s ( ABBV , Financial) next-generation immunology drug is closer to fulfilling its promise to help ease the pain caused by the imminent loss of patent protection for the company's multibillio...

3 weeks ago - GuruFocus

NORTH CHICAGO, Ill., July 7, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its second-quarter 2021 financial results on Friday, July 30, 2021, before the market opens.

3 weeks ago - PRNewsWire

Looking to buy and forget a stock? Look no further.

Other stocks mentioned: BAC, DELL
3 weeks ago - The Motley Fool

AstraZeneca (AZN), AbbVie (ABBV) and Bayer (BAYRY) are three large drug sector companies worth buying now.

Other stocks mentioned: AZN, BAYRY
3 weeks ago - Zacks Investment Research

Most stocks are priced at a premium. But these are bargains that also offer solid dividends.

Other stocks mentioned: BMY, VTRS
3 weeks ago - The Motley Fool

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?

3 weeks ago - Zacks Investment Research

ABBV vs. NVO: Which Stock Is the Better Value Option?

Other stocks mentioned: NVO
3 weeks ago - Zacks Investment Research

About ABBV

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, mar... [Read more...]

Industry
Drug Manufacturers-General
CEO
Richard Gonzalez
Employees
48,000
Stock Exchange
NYSE
Ticker Symbol
ABBV
Full Company Profile

Financial Performance

In 2020, AbbVie's revenue was $45.80 billion, an increase of 37.69% compared to the previous year's $33.27 billion. Earnings were $4.62 billion, a decrease of -41.44%.

Financial Statements

Analyst Forecasts

According to 22 analysts, the average rating for AbbVie stock is "Buy." The 12-month stock price forecast is 124.08, which is an increase of 4.38% from the latest price.

Price Target
$124.08
(4.38% upside)
Analyst Consensus: Buy